SCHEMBL4429564

SCHEMBL4429564

CCOC(=O)c1ccc(-c2ccc(-c3ccccc3)cc2)[nH]c1=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 2/20 0.68
KDM4E B2RXH2 5/20 0.59
ALDH1A1 P00352 5/20 0.51
GAA P10253 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
RXFP1 Q9HBX9 1/20 0.51
PDE3B Q13370 2/20 0.51
PDE3A Q14432 2/20 0.51
TSHR P16473 1/20 0.50
LMNA P02545 1/20 0.49
MAPT P10636 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
TUBB4A P04350 1/20 0.48
TUBB P07437 1/20 0.48
TUBA3C P0DPH7 1/20 0.48
TUBA1B P68363 1/20 0.48
TUBA4A P68366 1/20 0.48
TUBB4B P68371 1/20 0.48
TUBB3 Q13509 1/20 0.48
TUBB2A Q13885 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12427049 0.84 KDM4E (0.64) MDM2KDM4EALDH1A1GAASMN1; SMN2
SCHEMBL4437640 0.81 KDM4E (0.68) MDM2KDM4EALDH1A1GAASMN1; SMN2
SCHEMBL9260068 0.80 MDM2 (0.54) MDM2KDM4EALDH1A1GAASMN1; SMN2
SCHEMBL4429820 0.79 KDM4E (0.93) KDM4EALDH1A1GAASMN1; SMN2RXFP1
SCHEMBL1222162 0.78 LMNA (0.55) MDM2KDM4EALDH1A1GAASMN1; SMN2
SCHEMBL6110541 0.77 TSHR (0.56) KDM4EALDH1A1GAASMN1; SMN2TSHR
SCHEMBL14252251 0.76 TSHR (0.65) KDM4EALDH1A1GAASMN1; SMN2TSHR
SCHEMBL8121938 0.76 ALDH1A1 (0.60) MDM2KDM4EALDH1A1GAATSHR
SCHEMBL1156069 0.75 BRD4 (0.63) MDM2KDM4EALDH1A1GAASMN1; SMN2
SCHEMBL4074628 0.75 KDM4E (1.00) MDM2KDM4EALDH1A1GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125739-A1 MODULATORS OF C3A RECEPTOR AND METHODS OF USE THEREOF ENCYSIVE PHARMACEUTICALS, INC. (US) 2009-12-02 EP disclosed
WO-2008079371-A1 MODULATORS OF C3A RECEPTOR AND METHODS OF USE THEREOF ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-07-03 WO disclosed